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Human adenovirus (Ad) serotype 3 causes respiratory infections. It is considered highly virulent, accounting for about 13% of all Ad isolates.
We report here the complete Ad3 DNA sequence of 35,343 base pairs (GenBank accession DQ086466). Ad3 shares 96.43% nucleotide identity
with Ad7, another virulent subspecies B1 serotype, and 82.56 and 62.75% identity with the less virulent species B2 Ad11 and species C Ad5,
respectively. The genomic organization of Ad3 is similar to the other human Ads comprising five early transcription units, E1A, E1B, E2, E3, and
E4, two delayed early units IX and IVa2, and the major late unit, in total 39 putative and 7 hypothetical open reading frames. A recombinant E1-
deleted Ad3 was generated on a bacterial artificial chromosome. This prototypic virus efficiently transduced CD46-positive rodent and human
cells. Our results will help in clarifying the biology and pathology of adenoviruses and enhance therapeutic applications of viral vectors in clinical
settings.
D 2005 Elsevier Inc. All rights reserved.Keywords: Human adenovirus type 3; Species B1 adenovirus; Gene transfer vector; Bacterial artificial chromosomeIntroduction
Today’s major Ad vectors used in clinical applications are
derived from the species C serotypes Ad2 and Ad5 which
efficiently infect a variety of post-mitotic cells, including
specialized tissues of the upper respiratory epithelium and the
gut, in addition to many tumor cells. Their biology is very well
characterized (for reviews, see, Meier and Greber, 2003;
Russell, 2000; Shenk, 2001). Species C entry into epithelial
cells occurs after virus binding to the Coxsackie virus B Ad
receptor (CAR) (Bergelson et al., 1997) followed by engage-
ment of av containing heterodimeric integrins as secondary
receptors (Wickham et al., 1993), which facilitate viral
endocytosis and signaling into target cells (Meier et al.,0042-6822/$ - see front matter D 2005 Elsevier Inc. All rights reserved.
doi:10.1016/j.virol.2005.08.024
Abbreviations: Ad, adenovirus; BAC, bacterial artificial chromosome;
CAR, Coxsackie virus B and Ad receptor; ITR, inverted terminal repeat; kbp,
kilo base pairs; MLP, major late promoter; MOI, multiplicity of infection; mu,
map units; ORF, open reading frame.
* Corresponding author. Fax: +41 44 635 6811.
E-mail address: hemmi@molbio.unizh.ch (S. Hemmi).2002; Suomalainen et al., 1999). Although species C Ads
efficiently infect a number of cells and tissues, the lack of CAR
or integrin expression may limit their general usefulness for
gene therapy.
Recently, recombinant species B Ads or fiber swapped Ad
vectors in which the fiber protein of the commonly used Ad5 is
swapped with species B Ad fibers have gained interest for gene
therapy and vaccination approaches. Species B Ads are divided
into B1 and B2 subspecies. The B1 group comprises of Ad3,
Ad7, Ad16, Ad21, and Ad50 and predominantly infects the
upper respiratory tract, whereas the B2 group serotypes Ad11,
Ad14, Ad34, and Ad35 are associated with kidney and urinary
tract infections (Schmitz et al., 1983; Wadell, 2000). Infections
with B1 Ads are a major cause of acute febrile and severe
respiratory illness among military recruits (Dudding et al.,
1972). In particular, the widespread Ad3 and Ad7 account for
13% and 19.7% of all Ad isolates typed and reported to WHO
(Wadell, 2000). They are considered highly virulent and have
been associated with acute clinical manifestations of consider-
able severity, residual lung damage, and fatal outcomes in
children and military recruits in the US (for recent report, see5) 283 – 298
www.e
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identified (Li and Wadell, 1988). These variants have been
noticed to segregate in different geographic areas, time periods,
and clinical conditions.
A major difference between the species C and the species B
Ads is the receptor usage, which might help the species B Ads to
overcome host restrictions, as suggested in early studies (Defer
et al., 1990; Di Guilmi et al., 1995; Gall et al., 1996; Roelvink et
al., 1998; Stevenson et al., 1995). Using different approaches,
several groups have recently identified the membrane cofactor
CD46 as an attachment receptor for species B serotypes,
including Ad11 (Segerman et al., 2003), Ad35 (Gaggar et al.,
2003), and Ad3 (Sirena et al., 2004). Most of the downstream
steps of productive virus infection are, however, unknown. It is
for example unclear if integrins or other proteins act as
secondary receptors for virus uptake (Mathias et al., 1994;
Shayakhmetov et al., 2000) or if virus attachment to CD46 is
sufficient for uptake as CD46 is apparently internalized by
multiple endocytic pathways in noninfected cells, including
macropinocytosis and clathrin-mediated endocytosis (Crimeen-
Irwin et al., 2003). Despite this shortage of knowledge,
recombinant species B-based replication defective vectors have
been developed for Ad35 (Gao et al., 2003; Sakurai et al., 2003;
Seshidhar Reddy et al., 2003; Vogels et al., 2003) and Ad11
(Holterman et al., 2004; Stone et al., 2005). Interestingly, these
vectors show an extended tropism compared to species C vectors
and infect hematopoietic and dendritic cells. Similarly, replica-Table 1
Previously published human adenovirus 3 sequences used for primer design
Sequence origin GenBank
Accession No.
Referen
Ad3 complete sequence DQ086466 This pu
Ad3 left end fragment containing ITR, E1A (Cogan
Ad3 ITR, left end J01960 (Tolun
Ad3 ITR, left end J01963 (Kostu
Ad3 E1A 9S protein, E1A 13S protein, and
E1A 12S protein genes, complete cds
AF492352 (Avvak
Ad3 E1A protein gene, partial cds AY380316 Lin et
Ad3 polypeptide IX gene, complete cds J01962 (Engle
Ad3 DNA polymerase gene, partial cds AY780207 Chmie
unpubl
Ad3 virus-associated RNA, pre-terminal protein
and 52/55-kDa protein genes, partial cds
U52534 Ma et
Ad3 virus-associated RNA I and RNA II genes U10680 (Kidd
Ad3 gene for pIIIa, pVII and penton base protein Z29487 (Cuzan
Ad3 hexon gene X76549 (Pring-
Ad3 hexon gene, partial cds (nonfunctional) AY380317 Lin et
Ad3 hexon gene, partial cds AY684873 Ju et a
Ad3 L3–23-kDa gene for chymotrypsin-like
endoprotease
X13271 (Houde
Ad3 E3 region M15952 (Signas
Ad3 fiber polypeptide gene X01998 (Signas
Ad3 fiber protein gene, partial cds AY380318 Lin et
Ad3 ITR, right end J01961 (Tolun
Cds, coding sequence; ITR, inverted terminal repeat; aa, amino acid residue.tion-competent or replication-defective viral vectors derived
from Ad7 have been used for vaccine strategies (Abrahamsen et
al., 1997; Lubeck et al., 1989; Nan et al., 2003). An extended
tropism was also demonstrated for fiber swapped Ad vectors
containing fibers of species B viruses such as Ad3 (Kanerva et
al., 2002; Stevenson et al., 1997; Von Seggern et al., 2000), Ad11
(Stecher et al., 2001), and Ad35 (Havenga et al., 2001; Havenga
et al., 2002; Knaan-Shanzer et al., 2001; Rea et al., 2001;
Shayakhmetov et al., 2000; Yotnda et al., 2001). To generate a
tool for characterization of host cell–Ad3 interactions, we
constructed a recombinant E1-deleted Ad3 vector expressing
eGFP using the bacterial artificial chromosome (BAC) strategy,
and we report here the complete nucleotide sequence of serotype
Ad3 (GB) (GenBank accession no. DQ086466). This informa-
tion will serve as a reference for further characterization of this
prototype species B virus strain and facilitate the development
of genome-based molecular diagnostic tools of Ad infections.
Results and discussion
Nucleotide sequence and genome organization
Based on primers deduced from partial Ad3 sequences
(Table 1), the full genomic sequence of Ad3 prototype GB with
an overall size of 35,343 base pairs was determined by
sequencing both strands using the progressive specific primer
method (GenBank accession no. DQ086466). Sequencece % Homology compared to
the discussed sequence
(number of differences)
Region (bp)
blication 1–35,342
et al., 1992) 99.24 (12/1572) 1–1569
et al., 1979) 99.4 (1/158) 3–160
rko et al., 1982) 95.8 (32/770) 12–762
umov et al., 2002) 100 576–1455
al., 2003, unpublished 99.3 (3/430) 704–1134
r, 1981) 100 3413–3965
lewicz et al., 2004,
ished
100 5398–5646
al., 1996, unpublished 98.3 (10/582) 10,305–10,890
et al., 1995) 99.7 (1/450) 10,399–10,849
ge et al., 1994) 99.8 (3/1986)
(penton 100%
identical)
13,686–15,668
(13,905–15,540)
Akerblom et al., 1995) 99.6 (10/2835)
(hexon 3 aa
differences)
18,417–21,251
al., 2003, unpublished 97.7 (18/778) 18,524–19,295
l., 2004, unpublished 98.7 (5/397) 19,010–19,406
and Weber, 1988) 99.8 (2/1273) 20,917–22,190
et al., 1986) 99.9 (3/4379) 26,993–31,372
et al., 1985) 100 31,118–32,447
al., 2003, unpublished 98.7 (9/673) 31,406–32,079
et al., 1979) 99.4 (1/158) 35,183–35,340
Table 2
Base composition and GC contents of selected human adenovirus genomes
Ad species Ad serotype GenBank Mol% % GC
Accession No.
A C G T
content
A Ad12 NC001460 27.34 23.48 23.04 26.14 46.52
B1 Ad3 DQ086466 25.29 25.72 25.33 23.66 51.05
B1 Ad7 AY594255 25.37 25.78 25.25 23.61 51.03
B2 Ad11p AF532578,
AY163756,
AY598970a
26.04 24.42 24.46 25.08 48.88
B2 Ad35p AY271307 26.04 24.40 24.49 25.08 48.88
C Ad5 AC000008 23.29 28.03 27.16 21.51 55.20
D Ad17 AF108105 22.76 28.14 28.44 20.66 56.58
E Ad4 AY458656 21.95 28.93 28.72 20.39 57.65
F Ad40 L19443 24.87 26.21 25.01 23.91 51.22
a Although all three sequences show identical base composition, AY598970 differs by four and AF532578 by eleven nucleotides positions from AY163756.
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partial sequences varies between 95.8 and 100% (Table 1).
Some of these differences may reflect genuine variations
among strains or may have resulted from cloning artifacts or
sequencing errors. This is also illustrated by a comparison of
three recently determined prototype Ad11p sequences, where
sequence discrepancies were reported in four or eleven of the
34,794 nucleotide positions (Holterman et al., 2004). Further-
more, contaminations of standard virus stocks have been
noticed (Purkayastha et al., 2005a).
The Ad3 plus strand has a base composition of 25.29% A,
25.72% C, 25.33% G, and 23.66% T (Table 2). The overall GC
content of Ad3 is 51.05%, which is well within the reported
range of 50–52% for species B serotypes (Shenk, 2001) and
very similar to the 51.03% GC content of Ad7 (Purkayastha et
al., 2005b). In contrast, the GC content of B2 serotypes was
reported to be 48.88% for both Ad11 and Ad35. The 51.22%
GC content of Ad40 is closest to Ad3, whereas Ad5 of species
C, Ad17 of species D, and Ad4 of species E all have higher GC
content than Ad3 (Table 2). Nucleotide sequence comparison
between Ad3 and other human Ads revealed the highest degree
of identity to species B1 Ad7, amounting to 96.43% (Table 3)
followed by 82.56% identity to Ad11p and 82.45% to Ad35p,
both of species B2. Sequence identity to the species C Ad5,
species D Ad17, species E Ad4, and species F Ad40 amounted
to 62.75, 65.74, 73.18, and 59.44%, respectively. Thus, Ad3Table 3
Percent genome homology among selected human adenovirus genomes
Type Species
A B1 B1 B2 B2
Ad12
(NC001460)
Ad3 Ad7
(AY594255)
Ad11p
(AF532578)
Ad3
(AY
Ad12 100 60.14 60.35 60.17 59
Ad3 100 96.43 82.56 82
Ad7 100 83.65 82
Ad11p 100 98
Ad35p 100
Ad5
Ad17
Ad4
Ad40differs distinctly from the other human Ad species, with the
exception of B1 Ad7. The difference among the B1 serotypes is
comparable to the 98.14% identity found among the B2 Ad11/
35 serotypes or the 94.7% found among the Ad2/5 serotypes
(Chroboczek et al., 1992). The next closely related sequence to
Ad3 is the species E Ad4 (73.18% identity), in agreement with
the earlier notion that Ad4 exhibits close evolutionary
relationship to the species B viruses (Bailey and Mautner,
1994). On the other side, Ad4 revealed a closer phylogenetic
relationship with chimpanzee Ads (simian Ads) rather than
with other human Ads, which let to the speculation that human
Ad4, the single member of species E, emerged through a recent
zoonosis (Purkayastha et al., 2005a).
Subsequent analysis of the translational features of Ad3 led to
the identification of potential open reading frames (ORFs) with
sequences in general longer than 300 bp, comparison of the
deduced amino acid sequences to other members of the human
Mastadenovirus, in particular Ad5, 7, 11, and 35 (Chroboczek et
al., 1992; Gao et al., 2003; Mei et al., 2003; Purkayastha et al.,
2005b; Stone et al., 2003). Fig. 1 summarizes the Ad3 genome
organization containing the 39 identified putative coding
regions, the seven hypothetical coding regions, and the two
virus-associated (VA) RNAs. Similar to previously reported
sequences from other human Ad serotypes, Ad3 shows highly
organized genome structure with five early transcription units,
E1A, E1B, E2, E3, and E4, two delayed early units IX and IVa2,C D E F
5p
271307)
Ad5
(AC000008)
Ad17
(AF108105)
Ad4
(AY458656)
Ad40
(L19443)
.99 59.78 58.94 58.77 61.52
.45 62.75 65.74 73.18 59.44
.84 62.94 65.55 72.99 59.36
.14 61.54 63.62 70.17 59.16
61.59 63.69 70.22 59.15
100 62.71 64.23 58.94
100 68.86 59.69
100 60.17
100
Fig. 1. Genome organization of human Ad3. The map of the Ad3 genome (35,343 bp) is divided into 100 map units (mu). The genome consists of five early tra iption units, E1A, E1B, E2, E3, and E4, two delayed
early units IX and IVa2, and one late unit, the major late unit. 39 potential protein-coding regions and the direction of transcription are shown as solid arrows, tive to their position and orientation. Most late gene
transcripts contain the tripartite leader consisting of three spliced leader sequences (L1–L3) at their 5V ends. Splice events contributing to the transcript genera are indicated by diagonal thin lines. In addition, the
Ad3 genome encodes VA RNA I and II transcription units and seven hypothetical (hyp) ORFs with unknown biological functions.
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D. Sirena et al. / Virology 343 (2005) 283–298 287and one late unit, the major late unit MLTU. Several of these
potential Ad3 ORFs are novel, including seven hypothetical
ORFs that are conserved among other serotypes, but for which
no biological function has been reported. Their putative function
needs to be confirmed independently.
Noncoding motifs
Table 4 lists the predicted noncoding motifs of the Ad3
genome. The ITRs were confirmed to be 136 bp in length,
ending with the sequence CTATCTATAT as for Ad7. This
sequence differs from the consensus motif CATCATCAAT
found in most other human Ads sequenced so far, including
species B2 serotypes (Mei et al., 2003; Seshidhar Reddy et al.,
2003; Stone et al., 2005). The 136 bp ITR sequence reported here
is identical to the sequence reported earlier for human Ad3Table 4
Predicted noncoding motifs of the adenovirus 3 genome
Motif Description Position
CTATCT..TGACGT ITR 1–136
ATAATATACC DNApol-pTP binding site 9–18 (ITR)
TGGAATGGTGCCAA NFI binding motif 26–39 (ITR)
CATGTAAATGA NFIII binding motif 40–50 (ITR)
TATTTA TATA box for E1A 480–485
AATAAA PolyA signal for E1Aa 1494–1499
TATATA TATA box for E1B 1549–1554
TAAAGT TATA box for pIX 3384–3389
AATAAA PolyA signal pIXa 3909–3914
AATAAA PolyA signal for E2Ba
(overlapping with end of
cds)
3947–3952c
TGATTGGCTT Inverted CAAT box for
MLP
5821–5830
GGCCACGTGACC Upstream element for MLP 5840–5851
GCCGGGGGGG MAZ binding motif for
MLP
5862–5871
TATAAAAG TATA box for MLP 5872–5879
GGGGGCGGGCC MAZ/SP1 binding motif
for MLP
5879–5889
TCACTGT Initiator element for MLP 5901–5907
TTGTCAGTTTC DE1 for MLP 5988–5998
AACGAGGAGGATTTGA DE2a and DE2b for MLP 6003–6018
AATAAA PolyA signal for L1 13,830–13,835
AATAAA PolyA signal for L2a 17,496–17,501
AATAAA PolyA signal for L3a 21,938–21,943
AATAAA PolyA signal for E2Aa 21,950–21,955c
TTAA E2 TATA-box-like element 26,639–26,642c
TATAA TATA box for E3 27,085–27,089
AATAAA PolyA signal for L4 27,712–27,717
AATAAA PolyA signal for E3A 29,001–29,006
AATAAA PolyA signal for E3Ba 31,181–31,186
AATAAA PolyA signal for L5a 32,335–32,340
AATAAA PolyA signal for L6a 34,866–34,871
AATAAA PolyA signal for E4a 32,352–32,357c
TATATATT TATA box for E4 35,034–35,040c
ATAATATACC DNApol-pTP binding site 35,305–35,318c
CTATCT..TGACGT ITR 35,208–35,343c
The nucleotide positions of putative motifs are noted in the 5V to 3V orientation.
cds, coding sequence; ITR, inverted terminal repeat; MLP, major late promoter;
c, complementary.
a Splice site predicted using ERPIN RNA structure prediction (see Materials
and methods).(Tolun et al., 1979), except for a G–C mismatch at position 91.
Two further sequence determinations (Kosturko et al., 1982;
Cogan et al., 1992) confirmed our sequencing at this location
(note that the sequence reported by Cogan is not available in
electronic format). The entire Ad3 ITR sequence is very similar
to the 136 bp ITR of the closely related Ad7 (Greiner strain)
(Shinagawa and Padmanabhan, 1980), except for seven mis-
matches. Interestingly, recent sequencing of the Ad7 (Gomen
strain) suggested an ITR of only 108 bp (Purkayastha et al.,
2005b) and ten mismatched nucleotides compared to Ad3. The
terminal 22 nucleotides of Ad3 and Ad7 are identical to human
Ad4, in agreement with the earlier notion that Ad4 exhibits very
high sequence similarity in its E1A (0 to 5.5 map units) and E2
regions (62 to 66 map units) to group B Ads (Kitchingman,
1985; Tokunaga et al., 1986). The Ad3 ITR contains the
conserved ATAATATACC motif (base pairs 9 to 18), the
minimum sequence necessary to interact with a complex of
pTP and DNA polymerase during viral DNA replication (Chen
et al., 1990). The consensus binding motifs for the host factors
NFI/CTFI (bp 26 to 39) and NFIII/Oct-1 (bp 40 to 50) were
found to be located at positions similar to Ad5 (Hay et al., 1995).
Four canonical TATA box sequences conforming to the
consensus TATAWADR (W designating A or T, D designating
G, A, or T, and R designating G or A, respectively) were
identified, including those for E1B, E3, E4, and MLP (Table 4).
Furthermore, the E1A and E2A promoters contain the TATA-
like box elements TATTA and TTAA, respectively, as
described previously (Heysen et al., 1991; Kosturko et al.,
1982). The Ad3 E2A promoter contains one TATA-like box
less than Ad5. It was suggested that the lack of the second
TATA-like box together with the absence of a minor cap site
indicated that E2A and E2B transcripts both start at the same
major cap site (Heysen et al., 1991). The upstream sequence of
the Ad2 IVa2 promoter lacks a TATA element but contains an
unusual TATAGAAA element downstream of the transcription
start site at position +21 to +14 of the transcribed strand
(Carcamo et al., 1990). More distal IVa2 promoter elements
overlapping with the control region of the MLP may provide
additional transcriptional activations. Similarly, we identified a
TATA-like element TAAAGT about 40 nucleotides upstream of
the Ad3 protein IX promoter region apparently lacking a TATA
box as Ad5 (Engler, 1981). Our upstream element is identical
to the one recently described for Ad7 (Purkayastha et al.,
2005b). Furthermore, we identified thirteen polyadenylation
signal sequences, but we found no site for the E1B region. As
for Ad5, we found two polyadenylation signals in the E3
region, potentially giving rise to E3A and E3B transcripts. This
feature is absent in Ad4, Ad7, and Ad11, where only one
polyadenylation signal in E3 is known. A polyadenylation
signal was also found for the L6 region encoding the putative
agnoprotein (Mei et al., 2003).
Comparing ORFs of early regions
Table 5 lists the predicted sizes and positions of translation
initiation and termination for the 46 identified putative Ad3
ORFs. The early E1A gene gives rise to the first viral transcript
Table 5
Forty-six predicted translation products and VA RNA genes of the Ad3 genome
Feature MW
(kDa)a
Ad5 (others) equivalent ATG STOP
E1 region
E1A 13s protein 28.4 E1A 13s mRNA 32-kDa 576
j1250
1155
1455
E1A 12s protein 24.6 E1A 12s mRNA 26-kDa 576
j1250
1062
1455
E1A 9s protein 6.7 E1A 9s mRNA 6-kDa 576
j1250
647
1351
E1B 21-kDa 20.5 E1B 19-kDa 1603 2139
E1B 55-kDa 54.7 E1B 55-kDa 1908 3386
Intermediate transcription regions IX and IVa2
Protein IX 14.1 IX 3480 3896
Protein IVa2 50.6 IVa2 5572c
j5281c
5560c
3948c
E2 region
E2B DNA pol 128.6 DNA pol 8419c 5051c
E2B pTP 73.8 Terminal protein 10,344c 8422c
E2A DBP 58.3 DBP 23,557c 22,004c
E3 region
E3 12.1-kDa 12.1 E3 12.5-kDa 27,403 27,723
E3 16-kDa 16.0 27,677 28,117
E3 gp19-kDa 19.0 gp19-kDa 28,102 28,620
E3 20.1-kDa 20.0 28,650 29,189
E3 20.5-kDa 20.5 29,202 29,771
E3 9-kDa 9.0 29,786 30,019
E3 10.2-kDa 10.3 30,061 30,336
E3 15.2-kDa 15.2 30,341 30,745
E3 15.3-kDa 15.2 30,738 31,148
E4 region
E4 ORF1 14.1 E4 ORF1 34,953c 34,576c
E4 ORF2 16.0 E4 ORF B 34,579c 34,145c
E4 ORF3 13.6 E4 ORF3 34,148c 33,795c
E4 ORF4 14.3 E4 ORF4 33,786c 33,418c
E4 ORF6 34-kDa 34.7 E4 34-kDa 33,515c 32,616c
E4 ORF6/7 16.0 E4 ORF6/7 33,515c
j32,619c
33,342c
32,368c
VA RNA region
VA RNA I – VA I 10,422 10,591
VA RNA II – VA II 10,666 10,837
L region
L1 52/55-kDa 43.8 52/55-kDa protein 10,869 12,026
L1 pIIIa 65.7 Pro-IIIa 12,051 13,817
L2 III (penton
base)
61.8 Penton protein 13,905 15,539
L2 pVII 21.2 Pro-VII 15,551 16,129
L2 pV 40.1 Pro-V 16,172 17,221
L2 pX 8.3 Pro-X 17,250 17,477
L3 pVI 27.1 Pro-VI 17,553 18,305
L3 II (hexon) 106.2 Hexon 18,418 21,252
L3 23-kDa
(protease)
23.8 23-kDa (protease) 21,289 21,918
L4 100-kDa 92.3 L4 100-kDa protein 23,588 26,074
L4 22-kDa 22.5 22-kDa 25,776 26,375
L4 33-kDa 30.9 33-kDa 25,776
j26,294
26,244
26,649
L4 pVIII 24.9 Pro-VIII 26,720 27,403
L5 IV (fiber) 34.8 L5 IV fiber 31,368 32,327
L6 (agnoprotein,
hyp)
18.8 – 33,641 34,150
Miscellaneous proteins
20.3-kDa (hyp) 20.3 (Ad7/Ad4)
20.6-kDa/19.4-kDa (hyp)
5123 5692
11.5-kDa (hyp) 11.5 (Ad7/Ad11/Ad35/Ad4)
11.5-kDa (hyp)
6144 6464
Feature MW
(kDa)a
Ad5 (others) equivalent ATG STOP
Miscellaneous proteins
21.9-kDa (hyp) 21.9 (Ad7/Ad4/Ad11) (hyp) 7829 8425
14.6-kDa (hyp) 14.6 (Ad7/Ad4) 14.5-kDa
(hyp)
8548 8949
19-kDa (hyp) 19k (Ad7) E2B 19-kDa (hyp) 7389c 6868c
11.5-kDa (hyp) 11.5 (Ad7) E2B 11.3-kDa
(hyp)
9857c 9543c
C, complementary strand; j, join; hyp, hypothetical.
a Sizes determined from our sequences may deviate from previously
determined values.
Table 5 (continued)
D. Sirena et al. / Virology 343 (2005) 283–298288after DNA arrival in the nucleus (Shenk, 2001). The E1A
proteins are the major transactivators controlling viral replica-
tion. The putative splice variants of Ad3 13S, 12S, and 9S of
E1A were mapped according to previously published
sequences for the Ad3 E1 region (Avvakumov et al., 2002;
Cogan et al., 1992), the latter perfectly matching the herein
described sequence (Table 1). Similar E1A ORFs have been
described for other B species serotypes including Ad7
(Dijkema et al., 1980; Purkayastha et al., 2005b), Ad11 (Mei
et al., 2003; Stone et al., 2005), and Ad35 (Gao et al., 2003). In
the case of Ad5, the 13S, 12S, and 9S E1A proteins of 32, 26,
and 6 kDa are thought to arise by differential splice site
selection modulated by virus-induced stress signaling (Suoma-
lainen et al., 2001; van der Houven van Oordt et al., 2000).
The E1B region of Ad3 gives rise to two predicted proteins
of 21 and 55 kDa corresponding to the small and large T
antigen, respectively, representing the first report of an Ad3
E1B sequence. Similar E1B ORFs have been described for
other B species serotypes including Ad7 (Dijkema et al., 1982),
Ad11 (Mei et al., 2003; Stone et al., 2005), and Ad35 (Gao et
al., 2003). The 21- and 55-kDa proteins of Ad3 show identities
of 50 and 53% to Ad5 E1B proteins but show 99 and 98%
identity to Ad7 and 88 and 85% identity to Ad11, respectively
(Table 6). In the species C serotypes, both proteins are mainly
involved in counteracting apoptosis.
The DNA-binding protein (DBP) of E2A together with the
two genes of the early E2B region encoding the DNA
polymerase and the pre-terminal protein (pTP) provide the
machinery for viral replication. A detailed characterization of
the Ad3 E2A promoter (Heysen et al., 1991) and partial
sequences of the pTP and DNA polymerase are available from
the databank, but the sequence of the Ad3 DBP has not been
reported previously. The Ad3 58.3-kDa DBP, the 73.8-kDa
pTP, and the 128.6-kDa DNA polymerase revealed 54%, 80%,
and 76% identity to the corresponding Ad5 proteins. The two
zinc-binding domains in DBP were found to be fully conserved
among Ad3, Ad7, Ad11, and Ad5. The first zinc-binding
domain characterized by the consensus sequence HXCX8CXH
is located at amino acid positions 259 to 273. Four distributed
cystein residues at amino acid positions 383, 385, 437, and 454
characterize the second domain. The putative bipartite nuclear
localization signal 44PPKRN48 and 84PPKKKP89 in the N-
terminal domain of Ad11 DBP (Mei et al., 2003) is conserved
in Ad3 and in Ad7 (Purkayastha et al., 2005b).
Table 6
Comparison of primary amino-acid sequences of predicted Ad3 proteins with corresponding proteins of other human adenoviruses
Species
A B C D E F
B1 B2
Serotypes Ad12 Ad7 Ad16 Ad21 Ad11 Ad14 Ad35 Ad2 Ad5 Ad8 Ad9 Ad17 Ad36 Ad4 Ad40 Ad41
E1 region
E1A 12s protein 39 98 76 76 36 41 53 56 33 35
E1A 13s protein 42 98 98 96 78 88 77 36 36 58 43 44 58 57 40 42
E1A 9s protein 98 72 72 49
E1B 21-kDa 41 98 88 87 50 48 52 53 61 44
E1B 55-kDa 47 98 85 85 53 53 57 62 71 47
Intermediate transcription regions
Protein IX 58 100 88 89 51 51 61 78 57 57
Protein IVa2 78 99 93 93 82 82 85 85 91 80
E2 region
E2B DNA pol 73 98 91 91 76 76 81 80 88 72
E2B pTP 77 99 94 94 80 80 80 79 89 73
E2A DBP 50 96 83 83 54 54 60 59 74 51 51
E3 region
E3 12.1-kDa 67 99 100 99 87 88 88 55 55 66 66 66 79
E3 16-kDa 97 98 94 62 61 62 30 27 35 28 33 54
E3 gp19-kDa 23 98 98 98 80 70 80 32 36 35 35 34 63
E3 20.1-kDa 24 97 97 97 75 73 75 32 32 32 31
E3 20.5-kDa 96 97 98 62 61 62 33 27 33 33
E3 9-kDa 66 81 98 40 42 42 48
E3 10.2-kDa 52 100 98 100 93 95 93 51 47 65 64 75 42 43
E3 15.2-kDa 29 98 95 96 64 64 63 37 31 43 44 49 48 32 32
E3 15.3-kDa 56 87 87 88 86 86 86 49 53 74 77 76 79 51 51
E4 region
E4 ORF1 50 97 96 95 46 46 45 68
E4 ORF2 30 97 93 92 32 32 51 39 58 28
E4 ORF3 61 100 98 98 49 49 72 72 86 57
E4 ORF4 37 95 92 92 45 45 43 53 33
E4 ORF6 34-kDa 52 97 98 97 59 59 69 67 71 71
E4 ORF6/7 42 97 97 97 47 47 66 34
L region
L1 52/55-kDa 73 100 94 95 70 69 79 79 84 77
L1 IIIa 73 99 93 93 75 75 79 79 88 72
L2 III (penton base) 73 99 85 85 70 70 76 76 84 72 73
L2 pVII 74 98 91 91 69 69 81 87 69
L2 pV 59 99 84 84 61 60 65 64 79 57
L2 pX 62 100/99 92 92 69 69 77 88 67
L3 pVI 64 99 86 86 63 63 70 70 79 61
L3 II (hexon) 78 95 86 85 86 85 77 77 84 83 84 79 78
L3 23-kDa (protease) 81 98 89 89 80 80 83 79 89 81 83
L4 100-kDa 64 97 85 85 64 69 62 76 65 63
L4 22-kDa 43 98 78 77 50 51 53 63 73 45
L4 33-kDa 98 69 69 46 47 62 40 38
L4 pVIII 76 98 99 99 94 93 94 79 79 82 83 82 90 79 81
L5 IV (fiber) 33 57 62 58 58 57 58 29 29 28 28 31 31 31 27
L6 (agnoprotein) 97 94 95
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divergent part of the Ad genome (Bailey and Mautner, 1994).
The E3 polymorphism has been suggested to be in part
responsible for clinical manifestations, different for Ads of
different subspecies (Wold and Gooding, 1991). Depending on
the virus species, the E3 region encodes five to nine proteins
that are all involved in antagonizing the host immune response
to the viral infection (Horwitz, 2004). Although all seven Ad2/
5 E3 proteins and the unique Ad3 20.1- and 20.5-kDa E3
proteins are expressed during infection in cultured cells
(Burgert and Blusch, 2000), the E3 genomic region is entirelydispensable for virus growth in cell culture. Our sequence
analysis of E3 agrees with previous data by Signas et al.
(Tables 1 and 5, Fig. 1), which also identified nine putative
Ad3 ORFs (Signas et al., 1986). These include the RID a/h
10.3- and 15.2-kDa proteins and the 15.3-kDa protein, all three
of which are functionally conserved among all Ad species and
are homologues of the Ad5 10.4-, 14.5-, and 14.7-kDa
proteins. The Ad3 homologues of the Ad5 12.5- and gp19-
kDa proteins are 12.1- and gp19-kDa, respectively. They are
conserved in B, C, D, and E but not in F species. Two potential
Ad3 ORFs encode the 20.1- and 20.5-kDa proteins which are
D. Sirena et al. / Virology 343 (2005) 283–298290of interest because their genes are absent in species C (Signas
et al., 1986). They are absent or strongly diverged in species A
Ad12 and species F Ad40. The Ad3 9-kDa transmembrane
protein shares high homology only to the carboxy-terminal 20
amino acid end of the Ad2/5 11.6-kDa adenovirus death
protein (ADP). The function of this protein is unknown, but it
has high polymorphism among Ad3/7 field isolates (Kajon et
al., 2005), and notably, species B2 and F viruses lack the
potential 9-kDa/ADP ORF completely. The Ad7 homologue
appears to have diverged from the Ad3 E3 9-kDa sequence in
an unusual way (Hong et al., 1988) as it lacks the otherwise
conserved carboxy-terminal 20 amino acids but has an
insertion of 17 amino acids near the beginning of the potential
ORF, completely unrelated to Ad3 or Ad2/5. This leaves only a
central sequence with notable homology between Ad3 and Ad7
with a protein sequence identity of only 66%. Likewise, the
potential Ad3 ORF encoding the 16-kDa protein differs
substantially from Ad5 6.7 kDa equivalent. The proteins share
some conserved amino acids in the carboxy terminus and the
hydrophobic domain, but the Ad5 6.7-kDa protein lacks an 83-
residue extension at the amino-terminal end present in Ad3
(Wilson-Rawls et al., 1990).
The E4 unit is well conserved among the human Ads and
encodes at least six proteins involved in transcriptional
regulation, mRNA transport, DNA replication, and enhance-
ment or inhibition of apoptosis (Tauber and Dobner, 2001). A
blast search revealed no published sequences of the Ad3 E4
region. Six potential Ad3 ORFs were identified based on
sequence homology to Ad5. These include a 14.1-kDa protein
related to the Ad5 ORF 1, a 16-kDa ORF2 protein, a 13.6-kDa
ORF3 protein, a 14.3-kDa ORF4 protein, a 34.7-kDa ORF6
protein, and 16-kDa ORF6/7 protein. Their sequence identities
to the Ad5 sequences amount to 46, 32, 49, 45, 59, and 47%,
respectively, well within the range of similarity reported for E4
sequences of human species A–D (Tauber and Dobner, 2001).
The best-characterized E4 protein is ORF6, a multifunctional
protein participating in all of the abovementioned processes. It
contains several conserved motifs such as a cystein-rich domain
in the center with an HCHC motif critical for the zinc-binding in
vitro (Boyer and Ketner, 2000). We found a conservation of the
HCHC motif in Ad3 and also a conservation of an arginine-rich
amphipathic a-helix domain overlapping with a nuclear
retention signal of amino acids at position 236. Interestingly,
the Ad9 E4-ORF1 was recently reported to be an oncogenic
determinant and found to stimulate PI3-kinase via interaction
with a PDZ protein leading to mammary gland tumor in female
rats (Frese et al., 2003; Javier et al., 1992). The critical PDZ-
binding domain is conserved in the Ad3 sequence, but it is
unknown if this domain contributes to oncogenesis.
Seven hypothetical proteins were identified in the Ad3
genome as homologues of previously determined Ad2/5, Ad4,
Ad7, or Ad11 sequences. Six of these sequences are on a 5-kbp
stretch corresponding to the E2B region (Fig. 1). Four potential
ORFs are embedded on the sense strand and two on the
complementary strand. Due to a lack of biological data, no
annotation of these sequences to any of the transcription units
has been made yet.Comparing ORFs of intermediate genes and VA RNA regions
The viral genes encoding the proteins IVa2 and IX are
transcribed from their own promoters at an intermediate time
point of infection. Protein IVa2 has two important functions. It
is involved in packaging newly replicated viral DNA and has
transactivating properties on the MLP promoter, where it either
binds as a homodimer or a heterodimer (Young, 2003).
Functional interaction between IVa2 and the rest of the
packaging machinery appears to be serotype-specific. For
example, the species B1 Ad7 IVa2 protein cannot package an
Ad5 packaging sequence-containing chimeric virus (Zhang et
al., 2001). The sequence identity of 82% between Ad3 and Ad5
IVa2 is surprisingly high, suggesting additional functions of the
protein perhaps involved in housekeeping functions of adeno-
viral infections. As IVa2, protein IX has multiple functions
(reviewed in (Parks, 2005), including stabilization of the
capsid, transcriptional activation, and nuclear reorganization
during viral DNA replication and packaging of full-length viral
DNA genomes. A carboxy-terminal leucine repeat or coiled-
coil domain, conserved in the Ad3 sequence, is important for
the transcriptional activity of protein IX (Rosa-Calatrava et al.,
2001). Furthermore, Ads encode one or two small virus-
associated (VA) RNAs transcribed by the RNA polymerase III,
depending on the serotype. VA RNAs counteract the activity of
RNA-dependent protein kinase, up-regulated by the virus-
induced interferon response (Kitajewski et al., 1986). All
serotypes of species B1, including Ad3, Ad7, Ad16, and Ad21,
contain two segments encoding VA RNA I and II, in contrast to
species B2 or species A serotypes which only contain one VA
RNA (Kidd et al., 1995). In Ad3, the VA RNA I and II were
found to be located in tandem at nucleotide position 10,422 to
10,837 of the genome, comprising 416 nucleotides.
ORFs of late region
The Ad3 genome has six potential polyadenylation signals
similar to Ad11, suggesting that the late genes of Ad3 are
organized into six regions (L1–L6) expressed from the
common major late promoter MLP (Mei et al., 2003). As in
other human Ads, the MLP is located at 16.6 map units from
the conventional left hand end of the genome (Fig. 1, for
review on MLP, see Young, 2003). Several elements have been
described to control the MLP function of Ad2/5 and were
found here also for Ad3 (Table 4). These include the TATA box
and the initiator element INR and, in addition, upstream
elements such as the inverted CAAT box, upstream promoter
element UPR, and two downstream adjacent elements (DE1
and DE2b/a). The DE elements are binding sites for the IVa2
protein complex. Furthermore, two conserved GC-rich
sequences flanking the TATA box presumably functioning as
MAZ-, SP1- or TFIIB-binding sites were found in Ad3. A
surprisingly high 80% identity of the MLP and the first leader
segment of late RNAs had been noticed before between Ad3/7
and Ad2 (Engler et al., 1981), presumably reflecting the fact
that the DNA polymerase encoding sequence is located on the
opposite strand.
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(TPL) sequence of about 200 nucleotides, largely lacking
secondary structure. This feature allows the translation of the
downstream mRNA without the help of helicase functions,
which are impaired late in infection due to dephosphorylation
of eIF-4F (Huang and Schneider, 1991). eIF-4F helicase is
necessary for scanning of the 40S ribosomal subunit on most
cellular mRNAs. The TPL sequences thus give the viral
transcripts a selective translation advantage. The TPLs of Ad3
are situated at nucleotide position 5903 to 5943 (41 nucleo-
tides), nucleotide position 6962 to 7033 (72 nucleotides), and
nucleotide position 9477 to 9563 (87 nucleotides) (Fig. 1). The
overall length amounts to 200 nucleotides, identical to other
human Ads such as Ad5 and Ad11. The different MLP
transcription units encode ten of the eleven structural proteins
and four helper proteins. The Ad3 L1 encodes two potential
ORFs with homology to the 52/55-kDa protein and the
precursor of protein IIIa (pIIIa). This precursor is cleaved by
the viral 23-kDa protease, and the resulting pIIIa functions as a
cementing protein linking adjacent hexon proteins at the
icosahedral surface (Fabry et al., 2005). The conserved
cleavage site 568LGGR,G572 matches the substrate consensus
motif (M,L,I)XGX,G or (M,L,I)XGG,X of the Ad2/5 protease
(Tong, 2002). The identity between Ad3 and Ad5 pIIIa is 75%
and 99% between Ad3 and Ad7. Similar relationships of Ad3
to Ad5 and Ad7 are found for the 52/55-kDa protein, 69% and
100%, respectively.
Four Ad3 ORFs were identified corresponding to homo-
logues of the Ad5 L2 region. These include protein III (penton
base), the precursor proteins pVII, pV, and pX (also called A).
Penton base is one of three major capsid proteins, and it is
involved in virus uptake following binding of its RGD motif to
several av integrins (Wickham et al., 1993). The RGD motif
was found to be conserved in Ad3 penton base like in most
human Ad serotypes, as judged from partial sequence
information (Mathias et al., 1994). Our full-length Ad3 penton
base sequence revealed a 100% match to an earlier published
sequence (Cuzange et al., 1994). The Ad3 penton base protein
consists of 544 residues with 70% identity to Ad5 and 99%
identity to Ad7. The other proteins VII, V, and X are rich in
arginine and lysine, reflecting their function as DNA-binding
core proteins. Protein VII is the major core protein and serves
as a histone-like protein condensing the viral DNA. The
arginine/lysine content of Ad5 and Ad3 pVII is very similar,
24% and 23%, respectively, reflecting their similar functions.
The identities to the Ad5 homologues of pVII, pV, and pX are
69, 60, and 69%, respectively, whereas 98, 99, and 100 or
98.7% identities (for two different pX sequences) to the Ad7
homologues were found. Potential protease cleavage sites
recognized by the viral 23-kDa protease are conserved in pVII
and pX. The Ad3 pVII contains one potential cleavage site
(21MYGG,A25) and the pX two (24MLGR,G28 and
42LGGG,F46). No protease consensus motif was found in
Ad3 protein V, in agreement with Ad5.
The L3 region of Ad3 encodes three proteins with
homology to Ad5 proteins, the hexon (protein II), the 23-kDa
cysteine protease, the sequence of which was published before(Houde and Weber, 1988), and the precursor of protein VI. The
major capsid protein hexon is the most abundant structural
protein (San Martin and Burnett, 2003). It carries the serotype-
and species-specific determinants that are distributed over
seven hypervariable regions. The Ad3 hexon sequence has
been reported earlier (Table 1 and Pring-Akerblom et al.,
1995), and it is 95% identical to Ad7 and 77% to Ad5. P23 is
highly conserved among the different Ads. It catalyzes the
maturational processing of six proteins, the precursors of the
terminal protein (TP), protein IIIa, protein VI, protein VII,
protein VIII, and protein X (Mangel et al., 2003). Virions with
a defective protease assemble but fail to disassemble upon
internalization and are not infectious (Greber et al., 1996). P23
is activated by an 11-residue carboxy-terminal peptide cleaved
off from the precursor of VI (Mangel et al., 2003). This is
thought to happen during virion assembly in the vicinity of the
replicated viral DNA and might help recruiting protein VI to
the inner surface of the capsid, thus connecting hexon and the
viral DNA core. Similar to Ad2/5, two conserved viral protease
recognition sites near the N- and the C-terminus 30LNGG,A34
and 235IVGL,G240 are present in the Ad3 pVI precursor. In the
case of Ad2/5, the cleaved C-terminal peptide harbors nuclear
import and export signals, allowing the protein to shuttle
between the cytoplasm and link hexon to the nuclear import
machinery (Wodrich et al., 2003). This C-terminal peptide also
serves to activate the p23 protease switching protein VI
function from regulation to assembly. The function of the N-
terminal peptide is not known, although it has been suggested
that endosomal membrane disruption occurs by virtue of an N-
terminal amphipatic helix exposed upon proteolytic maturation
(Wiethoff et al., 2005). A putative amphipatic helix sequence
with hydrophobic residues is also conserved in Ad3. Precisely
how membrane lysis of Ad occurs and how this is controlled by
critical host factors (Meier et al., 2002; Meier et al., 2005) is
not known.
In the L4 region, four potential Ad3 ORFs with homology
to Ad5 genes were identified, the 100-kDa, 23-kDa, and 33-
kDa protein and the pVIII precursor protein. The 100-kDa
protein is not found in mature virions but acts as a scaffold to
facilitate assembly of hexon trimers and is involved in the
regulation of late viral protein synthesis (Shenk, 2001). For
Ad2, the latter has been suggested to depend on RNA-binding
motifs and a coiled-coiled motif at the amino acid position 280
to 345 allowing interactions with the eukaryotic initiation
factor eIF4G (Cuesta et al., 2004). A critical 329RRK331-motif
was found to be conserved in the Ad3 sequence. Ad3 100-kDa
protein is 97% identical to the Ad7 and 64% to the Ad5
protein. The 33-kDa phosphoprotein is involved in viral
assembly and shutoff of host cell translation (Fessler and
Young, 1999). The potential ORF for 33-kDa protein arises by
splicing of an intron sequence. In Ad3, an alternative potential
ORF encoding a 22-kDa protein with identical 156 amino-
terminal residues and a different carboxy-terminus of 43
residues is encoded by the first exon. The only biological
evidence for the existence of the smaller protein comes from
the finding that a virus mutant containing an early stop codon
in the first exon lost expression of two (faint) protein bands of
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the Ad7 homologue is 98% and 46% to the Ad5 homologue.
The pVIII precursor protein reveals a 98% identity to the Ad7
protein and 79% identity to the Ad5 protein. Within the 227
amino acid sequence, three viral protease cleavage sites are
conserved, starting at amino acid position 108, 128, and 154,
respectively. pVIII is thought to stabilize the capsid, but it is
not clear if it has additional functions and if all of the precursor
polypeptides are incorporated into virions (Fabry et al., 2005).
L5 and L6 each contain only one potential ORF, encoding
the fiber protein and the hypothetical unidentified agnoprotein.
The carboxy-terminal knob of the trimeric fiber protein
determines receptor binding, whereas the amino terminal
domain attaches noncovalently to the penton base protein.
The length of the shaft domains of species C and B viruses
differs considerably due to variation of the number of shaft
repeats. Like all other B species serotypes, Ad3 has short fiber
shafts. The Ad3 shaft lacks the KKTK sequence, a motif
suggested to bind heparan sulfate proteoglycans (Smith et al.,
2003). The Ad3 fiber sequence has a 29% identity to Ad5 fiber
and a 57% identity to Ad7 fiber, consistent with earlier
sequencing data (Signas et al., 1985). This confirms the notion
that the fiber proteins are the least conserved of all proteins
among the human Ad serotypes in terms of nucleic acid
sequence but not in terms of structure (Cusack, 2005). As the
putative ORF encoding the 169 amino acid residues agnopro-
tein is highly conserved in the species B genomes and is
followed by a polyadenylation signal not present in the Ad5
genome, it is likely to be expressed during infection (Mei et al.,
2003; Purkayastha et al., 2005b). It was speculated that this
hypothetical protein is a putative DNA-binding protein
(Purkayastha et al., 2005b).
Construction of an E1-deleted recombinant Ad3 vector
expressing eGFP
To establish a recombinant E1-deleted Ad3 vector expres-
sing the eGFP reporter protein, we initially employed
traditional cloning in E. coli as described earlier (Chartier et
al., 1996; Sirena et al., 2004). This attempt was based on
recABCD using moderate copy number entry vectors, and it
was not successful (data not shown). We thus employed the
single copy BAC vector pKSB2 as an acceptor, together with
the recently described ET recombination system (Zhang et al.,Fig. 2. Generation of a BACof E1-deletedAd3 encoding the eGFP reporter gene.
(A) The plasmid pBSAd3LRzeo contains a zeocin selection cassette flanked by a
468-bp fragment of the Ad3 left end sequence and a 528-bp fragment of the Ad3
right end sequence. (B) Transfer of the NotIB–HindIII fragment containing the
Ad3LRzeo cassette to the single copy pKSB2 plasmid. (C) Transformation of
DH10B bacteria expressing the phage lambda recombinases allows homologous
recombination between the SalI-linearized pKSB2Ad3LRzeo and Ad3 genomic
DNA, resulting in pKSBAd3wt. (D) Subsequent homologous recombination
between pKSBAd3wt and a CMV-eGFP/zeo cassette flanked by short
homologous sequences of 40 bp results in pKSB2 Ad3CMV-eGFP, which
contains the eGFP expression cassette in reverse orientation. (E) Release of the
viral genome by the flanking unique MluI endonuclease sites followed by
transfection of helper 911-Ad3E1B cells yieldingAd3CMV-eGFP. (For details of
the procedure, see Materials and methods.)2000). The pKSB2 plasmid supports stable maintenance of
large DNA fragments in E. coli. For the Ad3CMV-eGFP
construction, left and right terminal Ad3 sequences, separated
by a zeocin selection cassette, were first cloned into pBlue-
script (Fig. 2A, for details see Materials and methods) followed
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The resulting pKSB2Ad3LRzeo was linearized and co-trans-
formed together with wt Ad3 genomic DNA into E. coli
DH10B pre-transformed with pKD46, which encodes the
arabinose-inducible phage lambda recombinases (Fig. 2C).
Homologous recombination in these cells resulted in the
plasmid pKSB2Ad3wt containing the complete Ad3 genome.
In contrast to our initial attempts, the efficiency of this novel
recombination strategy was unexpectedly high as 9 out of 10
recovered clones carried full-length Ad3 genomes. Species C
and B derived recombinant Ad genomes have been reported to
be maintained as high or moderately high copy plasmids in E.
coli (Chartier et al., 1996; Hitt et al., 1997; Seshidhar Reddy et
al., 2003). Probably, this is not applicable for all Ad genomes,
including Ad3. It is known that some viral genomes are
unstable in E. coli as traditional plasmids. For example,
genomes from large DNA viruses, such as herpesviruses,
exceed the cloning capacity of normal cloning vectors and are
thus often manipulated in BACs (Messerle et al., 1997).
Besides the genome size, genome instability is another critical
factor as reported for coronaviruses which are only stable in E.
coli as BACs (Almazan et al., 2000). Whether the genome of
Ad3 is particularly unstable or whether the efficiency of the ET
recombination in our hands was much higher than the
efficiency of the recABCD system is not known yet.
In order to introduce the CMV-driven eGFP expression
cassette via a second homologous recombination, the PCR-
generated eGFP/zeo cassette flanked by short homologous
sequences was transformed into recombinase-expressing
DH10B cells harboring the pKSB2Ad3wt plasmid (Fig. 2D).
Insertion of the inverse-oriented expression cassette into the Ad3
sequence resulted in a 2469-bp deletion of the E1 region
encompassing the sequence from nucleotide 561 to 3029. This
deletion comprised the ORFs for E1A and most of E1B but left
intact a residual 409-bp stretch of the pIX promoter. Similar E1
deletions had been engineered in an E1-deleted Ad35 vector
(Gao et al., 2003). The resulting BACmid pKSB2Ad3CMV-
eGFP was digested withMluI to release the genomic DNA (Fig.
2E), which was subsequently transfected into helper 911-
Ad3E1B cells. GFP-positive plaques were detected under the
fluorescence microscope about 10 days post-transfection.
Plaque-purified clones were amplified and grown to high titers.
The predicted genome structure of Ad3CMV-eGFP was
confirmed by restriction analysis of isolated viral DNA (data
not shown).
In order to grow E1-deleted Ad3-based vectors, a modified
complementation cell line was produced that expressed the
Ad3 E1B 55-kDa protein. Expression of additional species B
E1B 55-kDa protein was previously demonstrated to be
sufficient to complement the E1 deletion of species B Ads,
when expressed in helper cell lines such as PER.C6 (Holterman
et al., 2004; Vogels et al., 2003) or HER293 (Gao et al., 2003).
We stably transfected 911 helper cells using the pPGK-
Ad3E1B-neo plasmid expressing the Ad3 E1B 55-kDa gene
under the housekeeping phosphoglycerate kinase (PGK)
promoter. Several clones were isolated and characterized for
their expression of Ad3 E1B 55-kDa protein and ability tosupport the growth of Ad3CMV-eGFP virus. The results
indicated that the Ad3 E1B 55-kDa protein was expressed at
low levels sufficient to grow plaqueing Ad3CMV-eGFP (data
not shown). For batch purification of Ad3CMV-eGFP, the 911-
Ad3E1B cells were additionally transiently transfected with the
pPGK-Ad3E1B-neo plasmid increasing the expression of the
limiting Ad3 E1B55K protein.
Transduction of CD46-positive target cells
We next measured Ad3CMV-eGFP-mediated gene delivery
to CD46-positive cells, including the stably transfected baby
hamster kidney cells BHK-CD46 (Sirena et al., 2004), the
human hematopoietic cell lines K562 and THP-1, and the
human lung carcinoma cell line A549, which expressed both
CD46 and the Coxsackie virus B Ad receptor CAR binding to
Ad2/5 vectors (Nagel et al., 2003). We compared the
transduction efficiency of Ad3CMV-eGFP, a chimeric Ad3
fiber-Ad5-based vector in which the fiber protein of Ad5 was
swapped with Ad3 (AdCMV-eGFP-5/F3) (Sirena et al., 2004),
and Ad5CMV-eGFP (Nagel et al., 2003). In CAR negative,
CD46-positive BHK-CD46 cells, both Ad3CMV-eGFP and
AdCMV-eGFP-5/F3 yielded dose-dependent eGFP expression,
about 75- and 39-fold higher than eGFP expression from the
Ad5 vector and 97- and 25-fold higher than CD46 negative
parental cells (MOI 30, Fig. 3). These results confirmed our
earlier notion that CD46 efficiently mediates uptake of both
Ad3 and Ad5/F3-chimeric viruses (Sirena et al., 2004). A
similar boost of transgene expression was found in CD46-
positive K562 cells and, to a lesser extent, in CD46-expressing
THP-1 cells. For CAR- and CD46-positive A549 cells, all three
recombinant vectors induced a robust transgene expression,
reaching highest levels with Ad3CMV-eGFP followed by
about 1.7-fold lower levels with AdCMV-eGFP-5/F3 and by
2.5-fold less eGFP with Ad5CMV-eGFP at MOI 3.3. Notably,
the transduction levels of CD46-positive cells with Ad3CMV-
eGFP were consistently higher with the chimeric AdCMV-
eGFP-5/F3. This effect was particularly pronounced with K562
cells, although the fractions of eGFP-positive cells were
comparable between the two viruses (data not shown). Similar
results were reported in a study of an Ad35 and Ad5/F35-
chimeric vector, where the Ad35 vector yielded more than 3-
fold higher transduction of human hematopoietic stem cells
than the chimeric vector, measuring the mean fluorescence
intensity of GFP or luciferase transgenes (Sakurai et al., 2003).
Although the luciferase cassette was inserted in the reverse
orientation, the authors speculated that this difference could
result from the different make up of the native Ad35 and the
Ad5 capsid bearing the Ad35 fibers, affecting virus entry.
Another study with an Ad11-eGFP and an Ad11 fiber swapped
Ad5, in contrast, reported that the percentage of transgene
expressing cells from both vectors were similar except in K562
cells where the chimeric vector was apparently superior (Stone
et al., 2005). These results may not be comparable since the
eGFP cassette of the Ad5/F11-chimeric vector was in the E3
region and in the E1 region of the Ad11-based vector. In our
case, it is possible that slight differences in expression levels
Fig. 3. Ad3-mediated e-GFP expression in permissive human cells and CD46-transfected rodent cells. The indicated cells were incubated with eGFP expressing Ad3,
Ad5, or Ad5/F3 at different MOIs. eGFP expression was analyzed 2 days post-infection by flow cytometry. Results are expressed as means of fluorescence intensity
(MFI).
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Ad3CMV-eGFP, as opposed to the Ad5-based vectors carrying
a forward orientated eGFP expression cassette.
Conclusions
We have determined the complete Ad3 sequence of 35,343
base pairs. Ad3 together with other B1 serotypes and species E
Ad4 belong to the causative agents of epidemic outbreaks of
acute respiratory disease. The complementation of the Ad3
sequence reported here may help to develop improved high-
throughput assays for genome typing, allowing to monitor
infectious diseases caused by this agent more accurately. The
transduction results obtained using the E1-deleted Ad3-based
eGFP vector revealed efficient entry of Ad3 into CD46-
positive cells. Future use of this vector may allow answering
specific questions concerning the entry pathway of Ad3 both in
vivo and in cultured cells.
Materials and methods
Cells and viruses
Most cells used here were described previously (Sirena et
al., 2004) and were grown in Dulbecco’s modified Eagle’s
medium (DMEM) plus 8% FCS. The molecular identity of the
Ad3 stock (prototype strain GB, kindly provided by the late T.
Adrian, Medizinische Hochschule Hannover, Germany) was
verified by DNA restriction analysis (Adrian et al., 1986). Ad3
was grown in A549 cells, and DNAwas isolated following the
protocol of Hardy et al. (1997).
Nucleotide sequence, gene organization, and sequence
comparison
Using isolated viral DNA, the nucleotide sequence of both
strands of the Ad3 genome was determined (GenBankaccession no. DQ086466) starting from the published
sequences for hexon (accession X76549 (Pring-Akerblom et
al., 1995)), E3 region (accession M15952 (Signas et al., 1986)),
penton base (accession Z29487 (Cuzange et al., 1994)), fiber
(accession X01998 (Signas et al., 1985)), E1A (accession
AF492352 (Avvakumov et al., 2002)), ITR and left end
(accession J01963 (Kosturko et al., 1982)), pIX (accession
J01962 (Engler, 1981)), and pTP (accession U52534; unpub-
lished). To confirm the exact ends of the ITR sequence, an
NheI 794 bp left end fragment was subcloned into XbaI–
EcoRV restricted pBluescript (ks+) (Stratagene). Sequencing
reactions were performed using primers of 18 to 22 nucleo-
tides and the chain termination kit ABI Big Dye Terminator
v.3.1 (Applied Biosystems, Foster City, CA, USA) and
subsequently analyzed on a 310 Genetic Analyzer (Perkin-
Elmer). The raw data were assembled and verified using the
sequence analysis software Sequencer (version 4.1, Gene
Codes Corporation, Ann Arbor, MI, USA). Identification of
putative open reading frames and the corresponding amino
acid sequences, as well as general sequence comparisons,
were performed using the GENtle GNU software (Mr. Magnus
Manske, Germany, http://gentle.magnusmanske.de). Identifi-
cation and sequence comparisons of the determined putative
proteins were performed with blastp from NCBI (http://
www.ncbi.nlm.nih.gov/BLAST/). Potential splice sites of
E1A were identified according to earlier published information
(accession AF492352 (Avvakumov et al., 2002)). Splice sites
of L4 22/23k IVa2 and E4 ORF6/7 genes were identified
using Wise2 (http://www.ebi.ac.uk/Wise2/) or NNSPLICE
version 0.9 (http://www.fruitfly.org/seq_tools/splice.html)
(Reese et al., 1997). PolyA signals were either predicted using
ERPIN (http://tagc.univ-mrs.fr/erpin/) (Gautheret and Lambert,
2001) (marked with asterisks in Table 4) or alternatively
identified based on polyA signals described for human Ad7
by Purkayastha et al. (2005a). The TATA box consensus
sequence was taken from: http://www.epd.isb-sib.ch/promoter_
elements.
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The recombinant Ad3 bacterial artificial chromosome
(BAC) was constructed by ET recombination (Zhang et al.,
2000) of Ad3 genomic DNA with a BAC-vector carrying
subcloned left and right terminal Ad3 fragments (Fig. 2). We
constructed the pBSAd3LRzeo plasmid containing the left and
right end of Ad3 genome as follows. Two PCR-generated
fragments were cloned into pBluescript (ks+). The first
fragment encompassed 468 bp of the Ad3 left end sequence
and was PCR-amplified using the forward primer 5V-GATCTC-
TAGACGCGTCTATCTATATAATATACCTTATAG-3V (insert-
ing the restriction sites XbaI and MluI) and the reverse primer
5V-GATCGAATTCGGTACCACTAGTATTTAAATTAGC-
GATCAGCTGACACC-3V (inserting the restriction sites SwaI
and EcoRI). This first fragment was cloned into pBluescript by
XbaI and EcoRI restriction sites. An additional cloning step
was used to introduce an AvrII site downstream of the EcoRI
site of this intermediate product. The second fragment
encompassed 528 bp of the Ad3 right end sequence and was
PCR-amplified using the forward primer 5V-AGAGCCTAG-
GAGCAAAGCCACCCCTCGCGG-3V (adding the restriction
site AvrII) and the reverse primer 5V-AAAAGGATC-
CACGCGTCTATCTATATAATATACCTTATAG-3V (adding
the sites MluI and BamHI). This second fragment was cloned
by AvrII and BamHI restriction sites. An AvrII–PvuII
fragment containing the zeocine resistance marker from
pcDNA3.1 zeo (Invitrogen) was cloned into the AvrII and
SwaI site, connecting the two Ad3 arms and resulting in
pBSAd3LRzeo. In order to transfer the Ad3LRzeo cassette to
the BACmid pKSB2, the NotI–HindIII fragment containing
this sequence was ligated with the NotI–HindIII-restricted
pKSB2 vector. The pKSB2 is a single copy plasmid that
supports stable maintenance of large DNA fragments in E. coli
and a derivative of the BAC vector pKSO (Messerle et al.,
1997) with a modified polylinker (PmeI–NsiI–PacI–NotI–
SfiI –ClaI –BamHI–SacII –HindIII). Colonies containing
pKSB2Ad3LRzeo were selected using chloramphenicol and
zeocini at concentrations of 10 Ag/ml and 25 Ag/ml,
respectively.
In order to generate pKSB2Ad3wt, which contained the
complete Ad3 genome, homologous recombination in DH10B
(Invitrogen) was performed. For this, chemically competent
DH10B cells were first transformed with the pKD46 plasmid,
which encodes the arabinose-inducible phage lambda recom-
binases reda (exo), redb (bet), and redc (gam) (Datsenko and
Wanner, 2000). For recombinase induction, DH10B bacteria
were grown at a reduced temperature of 30 -C (which is crucial
for maintenance of pKD46) in LB ampicillin (50 Ag/ml) and
0.1% (w/v) arabinose. Arabinose-induced electrocompetent
cells were co-transformed with SalI-linearized pKSB2Ad3LR-
zeo and genomic wt Ad3 DNA and were selected on
chloramphenicol plates. Nine of ten colonies revealed correct
integration in pKSB2Ad3wt, which was verified by BamHI
restriction analysis.
In order to insert the eGFP/zeo expression cassette into
pKSB2Ad3wt, DH10B bacteria containing the BACmid pKSB2Ad3wtwere re-transformedwith pKD46 and re-induced followed
by transformation with a PCR-amplified fragment containing an
eGFP/zeo cassette. The eGFP/zeo cassette contained the CMV-
driven eGFP gene and an EM7-driven zeocin resistance gene
derived from pcDNA3.1 zeo (Invitrogen). The expression
cassette was flanked by short homologous Ad3 sequences of 40
bp, which were introduced using the PCR forward primer 5V-
TGCCAGCGAGAAGAGTTTTCTCCTCCGCGCCGCAAGT-
CAGTCGGATCTGATCAGCACGTG-3V and the reverse primer
5V-TTGGTAATCACATTATGTTCAAATACAGGCCATTT-
TTTGCGAATTCATGTTCTTTCCTGC-3V. The sequence of the
forward primer was identical to Ad3 sequence 521 to 560,
whereas the second primer was identical to sequence 3030 to
3070, resulting in a 2469-bp deletion of the Ad3 E1 region. This
procedure deleted the ORFs encoding E1A and most of E1B but
left intact a residual 409-bp stretch of the pIX promoter, similar
as described for the Ad35-based vector by Gao et al. (2003). The
integrity of the resulting pKSBAd3CMV-eGFP was confirmed
by digesting isolated DNAswith restriction enzymesBamHI and
HindIII. Release of the viral genome by the flanking uniqueMluI
endonuclease sites was followed by transfection of helper 911-
Ad3E1B cells. Viral genomic DNAs from rescued virus particles
were analyzed using the above restriction enzymes. For large
batch preparation of Ad3CMV-eGFP, helper 911-Ad3E1B cells
were transiently transfected with the E1B-expression plasmid
pcDNA3PGK-Ad3E1B 55 kDa. For this, 2 Ag of the
pcDNA3PGK-Ad3E1B 55 kDa was calcium-phosphate-precip-
itated and added to 106 911-Ad3E1B cells (or multiples thereof
with adjusted DNA amounts). The medium was replaced after
8 to 12 h with DMEM 2% HS, and the cells were infected with
the recombinant Ad3CMV-eGFP. Virus was amplified using
methods described previously (Hemmi et al., 1998). CsCl
purification of Ad3CMV-eGFP yielded 1.6108 fluorescence
focus forming units. This rather low yield was likely due to the
transient nature of the complementing cells and may be
overcome in the future by using a stable cell line expressing
higher levels of Ad3 E1B 55-kDa protein.
Establishment of an Ad3 E1B-expressing packaging cell line
To allow the generation of E1-deleted Ad3-based vectors, a
modified 911 helper cell line (Fallaux et al., 1996) was
produced and characterized, similar as described for other
serotype B-based vectors (Gao et al., 2003; Holterman et al.,
2004; Vogels et al., 2003). For this, 106 911 cells were
transfected with 2 Ag of the pcDNA3PGK-Ad3E1B 55-kDa
plasmid using calcium phosphate precipitation. Following
transfection, G418-resistant 911-Ad3E1B cell clones were
established and analyzed by Western blotting for protein
expression. The pcDNA3PGK-Ad3E1B 55-kDa plasmid was
constructed in two steps. First, the CMV promoter in pcDNA3-
turbo-neo (Fleischli et al., in press) was removed withMfeI and
KpnI and replaced with an EcoRI–KpnI fragment of the mouse
phosphoglycerate kinase (PGK) promoter, excised from the
pPKGneo plasmid. In a second step, the Ad3 E1B 55-kDa
sequence was PCR-amplified using the forward primer 5V-
AAAGAATTCGGTGGCATGAGGTTCAGAGCG-3V in com-
D. Sirena et al. / Virology 343 (2005) 283–298296bination with the reverse primer 5V-AAATCTAGATTACT-
TATCGTCGTCATCCTTGTAATCGTCAGTTTCTTCAC-
CACTAGAACC-3V, which introduced a carboxy-terminal Flag-
tag. Following digestion with EcoRI and XbaI, the fragment
was cloned in the accordingly restricted pcDNA3PGK
vector.
Flow cytometry
For eGFP expression analysis, triplicates of 1105 cells
were infected at multiplicities of infection (MOIs) of 3.3, 10,
and 30, washed 2 h post-infection (p.i.) with RPMI 2% HS and
analyzed 2 days p.i. by flow cytometric analysis (Cytomics
FC500; Beckman Coulter, Fullerton, CA, USA). Mean
fluorescence intensities and the overall proportion of infected
viable cells were scored.
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